Suppr超能文献

C57BL/6J小鼠中取代苯丙胺的神经毒性概况

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

作者信息

O'Callaghan J P, Miller D B

机构信息

Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina.

出版信息

J Pharmacol Exp Ther. 1994 Aug;270(2):741-51.

PMID:8071867
Abstract

Dopaminergic (DA) and serotonergic (5-HT) projections to striatum and cortex have been implicated as the primary targets of substituted amphetamine (AMP)-induced neurotoxicity, largely on the basis of the propensity of these compounds to cause protracted decrements in DA and 5-HT rather than on the basis of AMP-induced alterations of indices linked to neural damage. Moreover, most studies of AMP-induced neurotoxicity, regardless of the endpoints assessed, have been conducted using a rat model; relatively little attention has been focused on the effects of these compounds in the mouse. Here, we evaluated the potential neurotoxic effects of d-methamphetamine (d-METH), d-methylenedioxyamphetamine (d-MDA), d-methylene-dioxymethamphetamine (d-MDMA) and d-fenfluramine (d-FEN) in the C57BL6/J mouse. Astrogliosis, assessed by quantification of glial fibrillary acidic protein (GFAP), was taken as the main index of AMP-induced neural damage. A silver degeneration stain also was used to obtain direct evidence of AMP-induced neuronal damage. Assays of tyrosine hydroxylase (TH), DA and 5-HT were used to assess effects on DA and 5-HT systems. Mice received d-METH (10 mg/kg), d-MDA (20 mg/kg), d-MDMA (20 mg/kg) or d-FEN (25 mg/kg) every 2 hr for a total of four s.c. injections. d-METH, d-MDA and d-MDMA caused a large (300%) increase in striatal GFAP that resolved by 3 weeks and a 50 to 75% decrease in TH and DA that did not resolve. d-METH, d-MDA and d-MDMA also caused fiber and terminal degeneration in striatum as revealed by silver staining. d-FEN did not affect any parameters in striatum. d-METH, d-MDA and d-MDMA also increased GFAP in cortex, effects that were associated with small (10-25%) and transient decrements in cortical 5-HT. d-FEN caused prolonged (weeks) decrements (20%) in cortical 5-HT but did not affect cortical GFAP. The effects of d-METH, d-MDA and d-MDMA were stereoselective and were blocked by pretreatment with MK-801. Core temperature was slightly elevated by d-METH, d-MDA and d-MDMA but was dramatically lowered by d-FEN. The data suggest that d-METH, d-MDA and d-MDMA, but not d-FEN, produce damage to neural elements of mouse striatum and cortex.

摘要

多巴胺能(DA)和5-羟色胺能(5-HT)向纹状体和皮质的投射被认为是苯丙胺替代物(AMP)诱导的神经毒性的主要靶点,这主要是基于这些化合物导致DA和5-HT长期减少的倾向,而不是基于AMP诱导的与神经损伤相关指标的改变。此外,大多数关于AMP诱导神经毒性的研究,无论评估的终点如何,都是使用大鼠模型进行的;相对较少关注这些化合物在小鼠中的作用。在此,我们评估了d-甲基苯丙胺(d-METH)、d-亚甲基二氧苯丙胺(d-MDA)、d-亚甲基二氧甲基苯丙胺(d-MDMA)和d-芬氟拉明(d-FEN)在C57BL6/J小鼠中的潜在神经毒性作用。通过定量胶质纤维酸性蛋白(GFAP)评估的星形胶质细胞增生被视为AMP诱导神经损伤的主要指标。还使用银染变性染色来获得AMP诱导神经元损伤的直接证据。酪氨酸羟化酶(TH)、DA和5-HT的测定用于评估对DA和5-HT系统的影响。小鼠每2小时接受一次d-METH(10mg/kg)、d-MDA(20mg/kg)、d-MDMA(20mg/kg)或d-FEN(25mg/kg),共进行四次皮下注射。d-METH、d-MDA和d-MDMA导致纹状体GFAP大幅增加(300%),3周后恢复,TH和DA减少50%至75%,未恢复。银染显示,d-METH、d-MDA和d-MDMA还导致纹状体纤维和终末变性。d-FEN对纹状体的任何参数均无影响。d-METH、d-MDA和d-MDMA还增加了皮质中的GFAP,这些影响与皮质5-HT的小幅(10 - 25%)和短暂减少有关。d-FEN导致皮质5-HT长期(数周)减少(20%),但不影响皮质GFAP。d-METH、d-MDA和d-MDMA的作用具有立体选择性,并被MK-801预处理阻断。d-METH、d-MDA和d-MDMA使核心体温略有升高,但d-FEN使其显著降低。数据表明,d-METH、d-MDA和d-MDMA而非d-FEN会对小鼠纹状体和皮质的神经元件造成损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验